Aperam SA (APAM)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 35.82 |
|---|---|
| 52-week range | 29.00 – 53.65 |
| Return, 1 month / 3 months | −20.8% / −23.3% |
| Return, 1 year / 3 years | +13.9% / +66.8% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 44.3% |
| Worst drawdown (1 year) | -31.7% |
| Average daily value traded | 0.10M EUR |
| Dividend yield | 5.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aperam is a stainless steel and specialty steel producer formed from the stainless operations of a larger steel group. The company makes stainless and electrical steels, along with related products such as precision strips and nickel alloys, at mills in Europe and Brazil. Its customers come from industries including automotive, appliances, construction, catering and industrial equipment, and it also runs a distribution and processing network serving those markets.
The shares are listed on the Madrid Exchange in Spain under the code APAM, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aperam SA (APAM) trades on the Madrid Exchange in Spain. It last closed at EUR 35.82 on 22 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 161 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.9% and over the last three months it fell 23.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 34 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.9% | ||
| From 52-week high | -32.4% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -23.3% | ||
| 6-month return | -11.8% | ||
| 12-month return, skipping the last month | 43.9% | ||
| Stability (higher is calmer) | 19 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.7% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.10M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 84 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.4% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −4.0% |
|---|---|
| 1 month | −20.8% |
| 3 months | −23.3% |
| 6 months | −11.8% |
| 1 year | +13.9% |
| 3 years | +66.8% |
| 5 years | −4.9% |
Signals
| 50-day / 200-day average | 43.65 / 42.57 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.38 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | EUR 0.5000 |
| 21 May 2026 | EUR 0.5000 |
| 24 Feb 2026 | EUR 0.5000 |
| 17 Nov 2025 | EUR 0.4250 |
| 14 Aug 2025 | EUR 0.4250 |
| 15 May 2025 | EUR 0.4250 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.